Our rapid liquid chromatography-mass spectrometry (rLC-MS) technology innovation and high throughput approaches have removed bioanalytical constraints to map dynamic, non-genetic biomarkers at speed, scale, and in a time- and cost-effective manner.
With more metabolite, lipid, and protein measures made in every sample, you can go beyond the genome to identify novel biomarkers that can inform and accelerate your studies for:
Fundamentally, Sapient’s proprietary rLC-MS allows us to take a biological sample like blood and, in that sample, capture and measure thousands of dynamic biomarkers.
We use these systems for discovery metabolomics and lipidomics, profiling broad, complex chemistries in a single run, as well as for discovery proteomics to significantly scale the number of proteins and proteoforms that can be measured in plasma.
This enables broader discovery to capture the most biologically relevant biomarkers, including yet-unknown molecules.
small molecule biomarkers measured in nontargeted method
proteins captured per human plasma biosample
samples can be analyzed per day with these systems
Connect with our scientists to discuss your project or the biological questions you want to answer. We’re here to help you apply robust, creative omics approaches at any phase of development.